Although these findings support a beneficial role of CSDE1 in glioma, a conflicting report suggests that CSDE1 promotes glioma cell migration and is significantly upregulated in patient samples compared to normal brain tissues (51). The gene discussed is CSDE1; the disease is central nervous system cancer.